跳至主要内容
临床试验/NCT01240174
NCT01240174已完成不适用

Demonstration of Near Zero Antibiotic Prescribing for Acute Bronchitis

Brigham and Women's Hospital1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2011年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
400
试验地点
1
主要终点
Antibiotic prescribing rate

研究概览

简要总结

Studies show, guidelines state, and performance measures assert that antibiotic prescribing for uncomplicated acute bronchitis is inappropriate. However, clinicians prescribe antimicrobials in over 60% of the 22.5 million acute bronchitis visits in the United States each year. Previous successful interventions have only reduced the antimicrobial prescribing rate to 40% or 50%. It is unknown if the antimicrobial prescribing rate for acute bronchitis can be brought to near zero percent in actual practice while maintaining patient safety and satisfaction. The goal of this study is to develop an Electronic Health Record (EHR)-integrated algorithm for the diagnosis and treatment of adults with acute bronchitis with a goal of reducing the antibiotic prescribing rate to near zero percent.

详细描述

We will use a multi-modal implementation - including computerized decision support, reporting tools, and clinician feedback - and quality improvement techniques to ensure adherence to the algorithm and reduce the antimicrobial prescribing rate to near zero percent. The duration of the intervention will be 4 years.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •first visit in 30 days, age 18-64, has a cough of less than 3 weeks duration

排除标准

  • •infiltrate on chest x-ray, has chronic lung disease

研究组 & 干预措施

Intervention Arm

Other

Single arm in the study of doctors receiving feedback about their antibiotic prescribing rate for acute bronchitis.

干预措施: Demonstration of near zero antibiotic prescribing for patients with acute bronchitis (Behavioral)

结局指标

主要结局

Antibiotic prescribing rate

时间窗: 30 days

The antibiotic prescribing rate for patients with acute bronchitis

次要结局

  • Patient symptoms(21 days)
  • Patient satisfaction(21 days)
  • Patient safety(30 days)
  • Healthcare costs(30 days)
  • The capture and description of the components that had the greatest effect on the antimicrobial prescribing rate(3 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeffrey A. Linder

Associate Physician

Brigham and Women's Hospital

研究点 (1)

Loading locations...

相似试验